Wendy Chen, MD, MPH
Alliance Study Chair
Dr. Chen is a Dana-Farber Cancer Institute breast cancer medical oncologist and cancer epidemiologist. She has worked with Dr. Holmes on many analyses and has led studies about the role of lifestyle and hormones on breast cancer risk and development.
Michelle Holmes, MD, DrPH
Dr. Holmes is a breast cancer epidemiologist at the Harvard T.H. Chan School of Public Health, associate physician at Brigham and Women’s Hospital, and associate professor of medicine at Harvard Medical School. She has led many key studies on factors that may affect breast cancer survival, including aspirin and lifestyle. She has a great deal of knowledge about the background and issues related to aspirin’s potential role in helping breast cancer survival.
Eric Winer, MD
Dr. Eric Winer is the director of the Dana-Farber Cancer Institute Breast Oncology Program, Susan F. Smith Center for Women's Cancers, and professor of medicine at Harvard Medical School. He is the immediate past co-chair of the Breast Cancer Committee for the Alliance for Clinical Trials in Oncology. The Alliance is one of four groups that make up the National Cancer Institute National Clinical Trials Network.
Maggie Carvan, MA, MPA
Ms. Carvan is a breast cancer survivor and advocate with experience as a consumer reviewer for the Department of Defense’s Congressionally Directed Medical Research Programs’ breast cancer panels. She is special assistant to the Heinz Family Philanthropies where she helped to plan a series of 13 national conferences on women, health, and the environment. Her volunteer patient advocacy activities include the Patient and Family Advisory Council and the Network for Patients and Families at the Massachusetts General Hospital Cancer Center. There she is matched with cancer patients to serve as a supporter and navigator on their cancer journey.
Ms. Matyka became a breast cancer advocate after her diagnosis in 1994. She has been involved in research and public policy on the state and national level, including expanding access to care, developing quality care guidelines, and recruiting patients for clinical trials. She is a member of the Breast Cancer Research Advocates at Dana-Farber Cancer Institute, a founding member and president of CARE Advocates Network (a regional breast cancer advocacy group), and the National Breast Cancer Coalition. She collaborates on a number of breast cancer research studies, has reviewed grant proposals for several funding organizations, and served on the National Advisory Committee of the Agency for Health Care Quality and Research.